Addex Therapeutics Ltd Stock Xetra
Equities
APE
CH0029850754
Biotechnology & Medical Research
Sales 2024 * | 1.2M 1.36M 1.24M | Sales 2025 * | 750K 848K 776K | Capitalization | 6.13M 6.94M 6.34M |
---|---|---|---|---|---|
Net income 2024 * | -4M -4.52M -4.14M | Net income 2025 * | -3M -3.39M -3.1M | EV / Sales 2024 * | 1.36 x |
Net cash position 2024 * | 4.5M 5.09M 4.65M | Net Debt 2025 * | 710K 802K 734K | EV / Sales 2025 * | 9.13 x |
P/E ratio 2024 * |
-2.08
x | P/E ratio 2025 * |
-2.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 35.04% |
Latest transcript on Addex Therapeutics Ltd
Managers | Title | Age | Since |
---|---|---|---|
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 38 | 17-05-31 |
Vincent Lawton
CHM | Chairman | 75 | 09-04-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jake Nunn
BRD | Director/Board Member | 53 | 18-05-31 |
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Vincent Lawton
CHM | Chairman | 75 | 09-04-15 |
1st Jan change | Capi. | |
---|---|---|
+24.74% | 47.54B | |
-0.47% | 41.96B | |
+43.96% | 41.55B | |
+25.40% | 30.36B | |
+17.96% | 27.61B | |
-4.47% | 28.7B | |
+50.73% | 14.7B | |
+42.56% | 13.51B | |
+1.46% | 12.34B |